Company introduction

Éloge France Vietnam was established on June 11, 2008, as a pharmaceutical joint venture between Vietnam and France. After a period of training, technology transfer, and factory construction, in September 2011, the company was certified by the Ministry of Health with GMP-WHO standards for three pharmaceutical production lines: Non-Betalactam, Penicillin, and Cephalosporin.

In 2019, Éloge achieved GMP-WHO certification for its health supplement production line. By 2020, the company expanded with two additional production lines for cosmetics and medical devices, meeting ISO 9001:2015 and ISO 13485:2016 standards.

With a vision to become a leading pharmaceutical and biotechnology company in Southeast Asia, Éloge places quality, innovation, and business ethics as its core values. The company is committed to delivering safe and effective products that contribute to improving community health.

Main Product

Dầu gội dược liệu Thập Thảo & xịt dưỡng tóc Thảo Dược

Basic Information

  • Industry: Wholesale pharmaceutical business
  • Year of establishment: 2008
  • Number of employees: 100
  • Main markets: Vietnam, Cambodia
  • Number of factories: 1
  • Owner's equity: 4,739,275.08 USD
  • Latest annual revenue: 4,073,453.54 USD
  • Export/Domestic revenue ratio: 1.5%
  • Representative name: Tran Minh Trung
  • Factory certifications: GMP-WHO compliant, ISO 9001:2015, and ISO 13485:2016

Contact person